Healthcare provider profile · identity verified

Benjamin A Rudin, M.D.

Internal Medicine · ADAMS, MA · NPI 1437131356

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	691	183
Omeprazole	Omeprazole	400	103
Amlodipine Besylate	Amlodipine Besylate	398	104
Lisinopril	Lisinopril	395	111
Hydrochlorothiazide	Hydrochlorothiazide	366	100
Levothyroxine Sodium	Levothyroxine Sodium	325	80
Lorazepam	Lorazepam	272	56
Eliquis	Apixaban	263	42
Sertraline Hcl	Sertraline Hcl	254	57
Metformin Hcl	Metformin Hcl	242	68
Metoprolol Succinate	Metoprolol Succinate	230	64
Losartan Potassium	Losartan Potassium	225	58
Gabapentin	Gabapentin	192	41
Furosemide	Furosemide	183	41
Metoprolol Tartrate	Metoprolol Tartrate	183	37
Tramadol Hcl	Tramadol Hcl	183	46
Rosuvastatin Calcium	Rosuvastatin Calcium	172	59
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	161	32
Alendronate Sodium	Alendronate Sodium	147	37
Prednisone	Prednisone	139	73
Albuterol Sulfate Hfa	Albuterol Sulfate	136	42
Simvastatin	Simvastatin	135	36
Tamsulosin Hcl	Tamsulosin Hcl	126	33
Pantoprazole Sodium	Pantoprazole Sodium	123	24
Clonazepam	Clonazepam	120	15
Trazodone Hcl	Trazodone Hcl	113	27
Oxycodone Hcl	Oxycodone Hcl	106	19
Zolpidem Tartrate	Zolpidem Tartrate	100	15
Clopidogrel	Clopidogrel Bisulfate	99	21
Allopurinol	Allopurinol	95	22
Escitalopram Oxalate	Escitalopram Oxalate	92	19
Jardiance	Empagliflozin	92	18
Duloxetine Hcl	Duloxetine Hcl	85	17
Lovastatin	Lovastatin	85	23
Ibuprofen	Ibuprofen	83	26
Fluticasone Propionate	Fluticasone Propionate	79	32
Valsartan	Valsartan	79	16
Venlafaxine Hcl Er	Venlafaxine Hcl	74	16
Famotidine	Famotidine	72	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	66	14
Diclofenac Sodium	Diclofenac Sodium	65	22
Quetiapine Fumarate	Quetiapine Fumarate	62	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	61	18
Warfarin Sodium	Warfarin Sodium	61	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	59	suppressed
Chlorthalidone	Chlorthalidone	57	14
Ozempic	Semaglutide	57	11
Pravastatin Sodium	Pravastatin Sodium	56	20
Synthroid	Levothyroxine Sodium	56	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	53	11
Mirtazapine	Mirtazapine	52	16
Tizanidine Hcl	Tizanidine Hcl	52	20
Glipizide	Glipizide	49	14
Ventolin Hfa	Albuterol Sulfate	47	12
Xarelto	Rivaroxaban	47	suppressed
Methadone Hcl	Methadone Hcl	45	suppressed
Breo Ellipta	Fluticasone/Vilanterol	44	suppressed
Alprazolam	Alprazolam	43	11
Januvia	Sitagliptin Phosphate	43	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	43	suppressed
Potassium Chloride	Potassium Chloride	43	suppressed
Cephalexin	Cephalexin	42	26
Finasteride	Finasteride	42	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	41	36
Carvedilol	Carvedilol	40	11
Donepezil Hcl	Donepezil Hcl	40	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	38	suppressed
Morphine Sulfate Er	Morphine Sulfate	37	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	37	28
Paxlovid	Nirmatrelvir/Ritonavir	36	36
Atenolol	Atenolol	35	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	11
Nortriptyline Hcl	Nortriptyline Hcl	35	suppressed
Paroxetine Hcl	Paroxetine Hcl	35	suppressed
Spironolactone	Spironolactone	35	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	13
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Glipizide Er	Glipizide	30	suppressed
Ondansetron Hcl	Ondansetron Hcl	28	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Naproxen	Naproxen	27	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	26	suppressed
Clonidine Hcl	Clonidine Hcl	26	suppressed
Ketoconazole	Ketoconazole	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Farxiga	Dapagliflozin Propanediol	25	suppressed
Lidocaine	Lidocaine	25	suppressed
Aripiprazole	Aripiprazole	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Enalapril Maleate	Enalapril Maleate	24	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Mupirocin	Mupirocin	23	13
Myrbetriq	Mirabegron	23	suppressed
Amoxicillin	Amoxicillin	22	15
Glimepiride	Glimepiride	22	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	22	suppressed
Torsemide	Torsemide	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Olanzapine	Olanzapine	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Azithromycin	Azithromycin	20	20
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	19	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	15
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	11
Doxycycline Hyclate	Doxycycline Hyclate	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Nystatin	Nystatin	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Divalproex Sodium Er	Divalproex Sodium	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Imipramine Hcl	Imipramine Hcl	16	suppressed
Methenamine Hippurate	Methenamine Hippurate	16	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	16	suppressed
Tiotropium Bromide	Tiotropium Bromide	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Celecoxib	Celecoxib	15	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	15	suppressed
Divalproex Sodium	Divalproex Sodium	15	suppressed
Indomethacin	Indomethacin	15	suppressed
Topiramate	Topiramate	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Bumetanide	Bumetanide	14	suppressed
Jantoven	Warfarin Sodium	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Morphine Sulfate	Morphine Sulfate	13	suppressed
Baclofen	Baclofen	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Lyrica	Pregabalin	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Testosterone	Testosterone	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Praluent Pen	Alirocumab	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error